Lappoxo (Omeprazole)

Omeprazole blocks the H+/K+ ATPase enzyme, also known as the proton pump, on gastric parietal cells. This inhibition stops the final step of acid secretion, leading to a sustained reduction in gastric acidity and an increase in stomach pH, which facilitates symptom relief and mucosal repair.

The appropriate dose of Lappoxo is determined by a qualified prescriber based on the specific indication, patient age, renal and hepatic function, and other clinical factors. Patients should follow the dosing instructions provided by their healthcare professional.

Safety of omeprazole during pregnancy or lactation should be evaluated by a healthcare provider. While some data suggest limited risk, the prescriber will weigh potential benefits against any possible risks to the mother and infant before recommending use.

To request Lappoxo, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lappoxo (omeprazole) belongs to the proton pump inhibitor class, which provides more potent and longer‑lasting acid suppression than H2‑receptor antagonists such as ranitidine. Compared with other PPIs, omeprazole has a well‑established efficacy and safety profile, though individual response may vary.

Lappoxo should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the tablets from moisture, excessive heat and direct sunlight to maintain product stability throughout its shelf life.

Lappoxo is taken orally, usually as a whole tablet with a glass of water. It can be taken with or without food, but consistency in timing relative to meals helps maintain predictable absorption. Follow the prescriber’s instructions regarding frequency and duration.

Serious but rare risks include severe allergic reactions (anaphylaxis), Clostridioides difficile‑associated diarrhoea, low magnesium levels, vitamin B12 deficiency with long‑term use, and increased risk of bone fractures. Patients should seek immediate medical attention if they experience symptoms such as rash, swelling, persistent diarrhoea, muscle cramps or unexplained fatigue.

Lappoxo is contraindicated in individuals with known hypersensitivity to omeprazole or any component of the formulation. Caution is advised for patients with severe liver disease, those taking certain interacting medications like clopidogrel, and patients with a history of allergic reactions to proton pump inhibitors.